REGENCELL BIOSCIENCE HOLDING (RGC) Stock Income Statement
NASDAQ:RGC - Nasdaq - KYG7487R1002 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | -60.00K | 60.00K | 190.00K | 150.00K | N/A | |||
| Operating Expenses | 4.40M | 4.74M | 6.27M | 7.62M | 1.38M | |||
| Research and Development | N/A | N/A | 1.58M | 2.51M | 440.00K | |||
| Selling, General, and Administrative Expenses | 3.31M | 3.67M | 4.69M | 5.11M | 940.00K | |||
| Operating Income | -4.40M | -4.74M | -6.27M | -7.62M | -1.38M | |||
| Other Income/Expense | 370.00K | 370.00K | 210.00K | 20.00K | 30.00K | |||
| Income Before Taxes | -4.03M | -4.36M | -6.06M | -7.59M | -1.35M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Net Income | -4.09M | -4.30M | -5.87M | -7.45M | -1.35M | |||
| EBITDA | N/A | -3.99M | -5.98M | -7.47M | -1.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 | |||
| Statistics | ||||||||
All data in USD